Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hearing01:31

Hearing

51.8K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
51.8K
Gene Therapy00:59

Gene Therapy

25.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.1K
The Cochlea01:13

The Cochlea

44.5K
The cochlea is a coiled structure in the inner ear that contains hair cells—the sensory receptors of the auditory system. Sound waves are transmitted to the cochlea by small bones attached to the eardrum called the ossicles, which vibrate the oval window that leads to the inner ear. This causes fluid in the chambers of the cochlea to move, vibrating the basilar membrane.
44.5K
Hair Cells01:22

Hair Cells

40.0K
Hair cells are the sensory receptors of the auditory system—they transduce mechanical sound waves into electrical energy that the nervous system can understand. Hair cells are located in the organ of Corti within the cochlea of the inner ear, between the basilar and tectorial membranes. The actual sensory receptors are called inner hair cells. The outer hair cells serve other functions, such as sound amplification in the cochlea, and are not discussed in detail here.
40.0K
What is Genetic Engineering?00:49

What is Genetic Engineering?

73.3K
Overview
73.3K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Live imaging and multimodal profiling reveal transdifferentiation of a cochlear supporting cell subpopulation upon Notch inhibition.

Science advances·2026
Same author

International expert consensus on gene therapy for hereditary hearing loss: Based on clinical trials.

Med (New York, N.Y.)·2025
Same author

DB-OTO Gene Therapy for Inherited Deafness.

The New England journal of medicine·2025
Same author

Electrophysiological Responses to Spectral Ripple Envelope Phase Inversion in 3-Month-Olds and Adults.

Ear and hearing·2025
Same author

A sound vision: MYO7A gene therapy reaches the inner ear.

The Journal of physiology·2025
Same author

AAV gene therapy rescues hearing and balance in a model of CLIC5 deafness.

EMBO molecular medicine·2025

Related Experiment Video

Updated: May 28, 2025

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
03:52

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

9.7K

Gene Therapy for Hearing Loss: Which Genes Next?

Ryan J Carlson1, Shahar Taiber2, Jay T Rubinstein3

  • 1Departments of Genome Sciences and Medicine, University of Washington, Seattle, Washington, USA.

Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology
|February 14, 2025
PubMed
Summary

Gene therapy shows promise for treating genetic hearing loss. Researchers identified key genes like TMPRSS3, PCDH15, and TMC1 as top candidates for developing effective treatments for sensorineural hearing loss.

More Related Videos

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
07:32

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Published on: March 16, 2015

15.5K
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice
09:34

Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice

Published on: May 25, 2018

10.7K

Related Experiment Videos

Last Updated: May 28, 2025

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
03:52

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

9.7K
Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
07:32

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Published on: March 16, 2015

15.5K
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice
09:34

Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice

Published on: May 25, 2018

10.7K

Area of Science:

  • Genetics
  • Otolaryngology
  • Molecular Biology

Background:

  • Genetic factors account for approximately 50% of childhood-onset sensorineural hearing loss.
  • Gene therapy is emerging as a viable treatment for hearing loss, with OTOF-associated hearing loss (DFNB9) already in clinical trials.
  • Developing therapies for other genetic causes of hearing loss requires prioritizing candidate genes.

Purpose of the Study:

  • To comprehensively evaluate nonsyndromic hearing loss genes for their potential as targets for gene therapy.
  • To identify and prioritize the most promising candidate genes for future therapeutic development.
  • To guide gene therapy efforts by assessing critical factors influencing treatment efficacy.

Main Methods:

  • A list of 93 supported nonsyndromic hearing loss genes was compiled.
  • Key evaluation criteria included gene size, cochlear degradation timing, primary expression cell types, mouse model availability, adeno-associated virus efficacy in mice, and human hearing loss characteristics (severity, onset, prevalence).
  • Gene-specific PubMed searches were conducted to gather data for each factor.

Main Results:

  • TMPRSS3, PCDH15, and TMC1 met all criteria, indicating they are highly promising candidates for gene therapy.
  • LOXHD1 and MYO6 also showed promise, despite lacking gene replacement attempts in mouse models.
  • The study systematically assessed 93 genes based on predefined criteria for gene therapy potential.

Conclusions:

  • Candidate genes for hearing loss gene therapy exhibit significant variability in their suitability for treatment.
  • Prioritizing development efforts on the identified promising candidates will maximize the chances of clinical success.
  • Several genes are poised to become key targets, highlighting the growing importance of gene therapy in managing hearing loss.